Guest guest Posted April 27, 2006 Report Share Posted April 27, 2006 http://www.truthout.org/docs_2006/042606H.shtml The Fight Against Hidden Diseases By Henri Pézerat Le Monde (France) Wednesday 26 April 2006 For several decades, government and medical actors in the field of prevention have essentially targeted tobacco-use among the causative factors for a certain number of cancers. Yet that is only one of the carcinogenic factors we must attack. But it is easier to make individuals feel guilty than to condemn those economic actors that don't hesitate to put products or technologies on the market capable of generating an increase in the incidence of cancers. We've seen it with asbestos exposures that will bring still another 50,000 to100,000 new deaths in their wake between now and 2025. This result could have been foreseen from the medical and scientific data as of the beginning of the 1960s. But the public health dignitaries didn't want to know about it, not in 1960, nor even in 1975 when other actors sounded the alarm. And we had to wait until 1997, following highly publicized social movements, to obtain a prohibition on the material. Which goes to show that cancer prevention has not only a medical, but also a social dimension. Beyond asbestos, we know of about 500 products or physical or technological agents considered as potentially cancer-producing in people, of which 100 with a strong degree of certainty. But prevention against these agents is only in its first steps. There have been only very few efforts to explain why the annual incidence of breast cancer has gone from 21,200 cases in 1980 to 41,800 cases in 2000. For those types of tumors, the research should bear principally on the relationship between cancers and endocrine-disruptors, a class of products, which, in addition to synthetic hormones, includes quantities of chemical products found in plastics, detergents, pesticides, etc. But that's an area in which all research - in both public and private institutions - is under the international chemical lobby's tight surveillance! Certainly, some epidemiological investigations here or there confirm knowledge gained through clinical work and toxicology. But to go beyond that, epidemiology must base itself on trans-disciplinary projects that include clinical work, toxicology, biology, sociology, expologie (which explores means of exposure). Yet, at present, it's parceling out and compartmentalization that rule, and epidemiology, which aspires to being a sovereign discipline, can only conform to pre-established, standardized models that lose sight of the ill and their environment. Research can only progress if it opens itself to all disciplines. In the research field of cancer etiology, the initial observation, the one that can generate an innovative project, is often that of cancer " clusters, " possibly affecting the same organ, limited in time and space. Most often, these clusters go unnoticed, or, when they are reported by isolated individuals, unions, or associations, they are rejected by institutions as due to chance, to what they call " statistical hazards, " an a priori rejection, with no in-depth investigation into the different possible hypotheses. And yet, in the area of work-related cancers, history teaches us that most products classified as carcinogens have been so classified from the starting point of cluster observation! Twenty years ago, [French] Social Security only recognized about a hundred cases of cancer provoked by workplace exposures; now it acknowledges over 1,500, 83% of which are imputed to asbestos exposure, but epidemiologists estimate that the real number of new cases annually is more on the order of 20,000! The understatement is consequently considerable, with strong responsibility on the part of a medical corps that is, certainly, poorly informed, but also, in general, little inclined to oppose the institutions and persons in power at the moment. The vast majority of carcinogens other than asbestos met with in the workplace give rise to only isolated observations, even though it is certain that there exist unidentified clusters in the absence of observers likely to sound the alarm. To impose public risk reconnaissance is, in fact, a difficult task, full of pitfalls to which few doctors or scientists would agree to harness themselves. I speak from experience, since, independently of the fight against asbestos conducted since 1975, I participate - alongside unions and/or associations - in this struggle to make carcinogenic factors visible in different companies. The main lesson we draw from these struggles is that the primary trump card that allows the existence of cancer clusters to be revealed is an alliance between a lucid, strong, and determined union movement inside a company and one or more scientific or medical actors. The discovery of clusters and their most likely origin is not - at first - the fruit of scientific and medical research as it is currently understood. That research, in its multiple dimensions, with in vitro and in vivo tests, mechanism studies, epidemiological investigations, exposure investigations, etc. only comes downstream of a preliminary fight, a fight which is, above all, social. Environmental cancers are more difficult to identify than work-related cancers, the dispersion of pollutants covering a far more vast geographic area and leading to much weaker concentrations of carcinogenic agents in the air than those met with in industrial surroundings. Overall, cancer clusters of children - with short latency periods - are undoubtedly the easiest to identify, since there does exist a privileged observation vantage point that gathers children from a given geographic area together: that is, school. My personal experience led me to become aware of two clusters of cases, in Vincennes and in Mortagne-au-Perche, both in the age range (0 to 5-7 years old) where the incidence of childhood cancers is highest. In general, if the feedback is adequate, there's a DDASS investigation, then one by the Institute for Sanitary Monitoring (InVS) and its regional relay stations. The conclusion of the investigations in the two examples of clusters that I know about were proclaimed even before the investigations took place. It could only be a " statistical hazard, " that is, a result of chance! A single example in Perche, with four cases of cancer in less than two years in a little school close to a meat-processing plant: the InVS closed the affair without any investigation of the factory. We demanded that the investigation be reopened, but the InVs answered that " no exposure to a known risk factor has been discovered, " and even that no such exposure could be discovered because, " the investigation of a cluster does not present conditions susceptible to the performance of etiological undertakings. " So then what's the point of the InVS? It remains indispensable in such a case to explore the hypothesis of a pollution of the village, in particular during a period of BSE epidemic when various attempts to destroy the pathogenic prion in animal meal by heat and pressure took place in the factory. Pollutants could then have been carcinogens formed when meat was heated above 100°C, known pollutants belonging to the amine heterocyclic family, all capable of inducing cancers in multiple organs. We note that such research would undoubtedly not be without consequences with regard to the understanding and prevention of cancers linked to diet! In fact, it seems that the first concern of governmental authorities is to avoid making any waves, to avoid implicating heavyweight economic actors or flawed administrations in any way. As far as research institutions are concerned, they appear, in this domain, incapable of initiative, without imagination: some directly influenced by representatives from industry, others paralyzed by the fear of displeasing or of bringing ripostes down on themselves that might hurt their image and research careers. Consequently, there will be no progress towards better cancer prevention unless the level of society's demands as a whole changes. Demands that imply collective and sustained action, not the blind trust so frequently demanded by medical and scientific institutions. -------- Henri Pézerat is honorary research director at the CNRS. (National Center for Scientific Research) Translation: t r u t h o u t French language correspondent Leslie Thatcher. ------- Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.